Next |
home / stock / neo / neo message board
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics Inc. Company Name:
NEO Stock Symbol:
NASDAQ Market:
Insights from 11 Abstracts Highlight Key Findings Across the Oncology Care Spectrum NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will present key findings from 11 abstracts at the American Association for Cancer Re...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today released its 2023 Environmental, Social, and Governance (ESG) Report highlighting progress toward building a more sustainable, diverse, and equitable company that delivers exceptional customer experience and...
2024-03-18 15:30:02 ET Piper Sandler analyst issues BUY recommendation for NEO on March 18, 2024 02:00PM ET. The previous analyst recommendation was Buy. NEO was trading at $14.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...